Early breast cancer without axillary lymph node involvement;Cancer du sein sans atteinte ganglionnaire axillaire

Cancer/Radiotherapie

Volumn 14, Issue SUPPL. 1, 2010, Pages

  Ghorbel, I ^a,b   Kanoun, S ^a,c   Kallel, A ^a,d   Belaid, A ^a,b   Azoury, F ^a   Heymann, S ^a   Pichenot, C ^a   Verstraet, R ^a   Marsiglia, H ^a,e   Bourgier, C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b SALAH AZAIEZ INSTITUTE   (Tunisia)

^c FARHAT HACHED HOSPITAL   (Tunisia)

^d Clinique Ennasr   (Tunisia)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Atlas; Conformal irradiation; Early breast cancer; Target volumes

Indexed keywords

ANATOMY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CASE REPORT; HUMAN; MAMMOGRAPHY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; SENTINEL LYMPH NODE BIOPSY; TREATMENT PLANNING;

AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FRANCE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAMMOGRAPHY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SENTINEL LYMPH NODE BIOPSY;

EID: 78649767226     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(10)70016-0     Document Type: Article

References (54)

1. Al Uwini S., Antonini N., Poortmans P.M., Boersma L., Hurkmans C., Leer J.W., et al. The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment. Radiother Oncol 2009, 93:87-93.
2. Althuis M.D., Dozier J.M., Anderson W.F., Devesa S.S., Brinton L.A. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005, 34:405-412.
3. Arriagada R., Le M.G., Contesso G., Guinebretiere J.M., Rochard F., Spielmann M. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 2002, 13:1404-1413.
4. Arriagada R., Le M.G., Guinebretiere J.M., Dunant A., Rochard F., Tursz T. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 2003, 14:1617-1622.
5. Arriagada R., Mouriesse H., Sarrazin D., Clark R.M., Deboer G. Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 1985, 11:1751-1757.
6. Azria D., Gourgou S., Sozzi W.J., Zouhair A., Mirimanoff R.O., Kramar A., et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 2004, 91:1251-1260.
7. Bartelink H, Boersma LJ, Leer JW, Poortmans P. The Intergroup Trial of the BOOG " The Young Boost Trial" BOOG 2004-01; CKTO 2003-13. Radiation dose intensity study in breast cancer in young women: a randomized phase III trial of additional dose to the tumor bed. 2004.
8. Bartelink H., Horiot J.C., Poortmans P., Struikmans H., Van den Bogaert W., Barillot I., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001, 345:1378-1387.
9. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-175.
10. Benda R.K., Yasuda G., Sethi A., Gabram S.G., Hinerman R.W., Mendenhall N.P. Breast boost: are we missing the target?. Cancer 2003, 97:905-909.
11. Cesaretti J.A., Stock R.G., Lehrer S., Atencio D.A., Bernstein J.L., Stone N.N., Wallenstein S., Green S., Loeb K., Kollmeier M., Smith M., Rosenstein B.S. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 2005, 61:196-202.
12. Chargari C., Fromantin I., Kirova Y.M. Importance of local skin treatments during radiotherapy for prevention and treatment of radio-induced epithelitis. Cancer Radiother 2009, 13:259-266.
13. Clarke D.H., Le M.G., Sarrazin D., Lacombe M.J., Fontaine F., Travagli J.P., et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985, 11:137-145.
14. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
15. Das I.J., Cheng E.C., Freedman G., Fowble B. Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer. Int J Radiat Oncol Biol Phys 1998, 42:11-19.
16. Delay E., Gosset J., Toussoun G., Delaporte T., Delbaere M. Post-treatment sequelae after breast cancer conservative surgery. Ann Chir Plast Esthet 2008, 53:135-152.
17. Dilhuydy J.M., Bussieres E., Romestaing P. Radiotherapy of the breast and chest wall: treatment volume. Cancer Radiother 2001, 5:550-559.
18. Dilhuydy M.H. Breast cancer screening: specific features of the French program. J Gynecol Obstet Biol Reprod (Paris) 2004, 33:683-691.
19. Dubray B. Late complications of radiotherapy. Role of the time factor. Bull Cancer Radiother 1995, 82:98-100.
20. Dubray B., Delanian S., Lefaix J.L. Late effects of mammary radiotherapy on skin and subcutaneous tissues. Cancer Radiother 1997, 1:744-752.
21. Dzhugashvili M., Pichenot C., Dunant A., Balleyguier C., Delaloge S., Mathieu M.C., et al. Surgical Clips Assist in the Visualization of the Lumpectomy Cavity in Three-Dimensional Conformal Accelerated Partial-Breast Irradiation. Int J Radiat Oncol Biol Phys 2009, Jul 11.
22. Elkhuizen P.H., van de Vijver M.J., Hermans J., Zonderland H.M., van de Velde C.J., Leer J.W. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998, 40:859-867.
23. Fernando I.N., Ford H.T., Powles T.J., Ashley S., Glees J.P., Torr M., et al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 1996, 8:226-233.
24. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
25. Fisher B., Anderson S., Fisher E.R., Redmond C., Wickerham D.L., et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991, 338:327-331.
26. Fisher J., Scott C., Stevens R., Marconi B., Champion L., Freedman G.M., et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000, 48:1307-1310.
27. Fong A., Bromley R., Beat M., Vien D., Dineley J., Morgan G. Dosimetric comparison of intensity modulated radiotherapy techniques and standard wedged tangents for whole breast radiotherapy. J Med Imaging Radiat Oncol 2009, 53:92-99.
28. Fourquet A., Campana F., Zafrani B., Mosseri V., Vielh P., Durand J.C., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989, 17:719-725.
29. Gagliardi G., Bjohle J., Lax I., Ottolenghi A., Eriksson F., Liedberg A., et al. Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 2000, 46:373-381.
30. Gagliardi G., Lax I., Soderstrom S., Gyenes G., Rutqvist L.E. Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. Radiother Oncol 1998, 46:63-71.
31. Giraud P., Cosset J.M. [Radiation toxicity to the heart: physiopathology and clinical data]. Bull Cancer 2004, 91:147-153.
32. Hernberg M., Virkkunen P., Maasilta P., Keyrilainen J., Blomqvist C., Bergh J., et al. Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study. Int J Radiat Oncol Biol Phys 2002, 52:128-136.
33. Huchet A., Caudry M., Belkacemi Y., Trouette R., Vendrely V., Causse N., et al. Effet volume en radiothérapie [II]. Deuxième partie: volume et tolérance des tissus sains. Cancer Radiother 2003, 7:353-362.
34. Huston T.L., Simmons R.M. Locally recurrent breast cancer after conservation therapy. Am J Surg 2005, 189:229-235.
35. Iannuzzi C.M., Atencio D.P., Green S., Stock R.G., Rosenstein B.S. ATM mutations in female breast cancer patients predict for an increase in radiationinduced late effects. Int J Radiat Oncol Biol Phys 2002, 52:606-613.
36. Jalali R., Singh S., Budrukkar A. Techniques of tumour bed boost irradiation in breast conserving therapy: current evidence and suggested guidelines. Acta Oncol 2007, 46:879-892.
37. Lartigau E., Dubray B., Mornex F. Biological mechanisms of late effects of ionizing radiations. Cancer Radiother 1997, 1:669-676.
38. Locker A.P., Ellis I.O., Morgan D.A., Elston C.W., Mitchell A., Blamey R.W. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 1989, 76:890-894.
39. Moody A.M., Mayles W.P., Bliss J.M., A'Hern R.P., Owen J.R., Regan J., et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 1994, 33:106-112.
40. Mosseau M., Garnier C. Cancer du sein: épidémiologie, bilan d'extension, modalités thérapeutiques. Médecine Nucléaire-Imagerie fonctionnelle et métabolique 2002, 26:7-21.
41. Nguyen P.L., Taghian A.G., Katz M.S., Niemierko A., Abi Raad R.F., Boon W.L., et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008, 26:2373-2378.
42. Nuyten D.S., Kreike B., Hart A.A., Chi J.T., Sneddon J.B., Wessels L.F., et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 2006, 8:R62.
43. Pommier P., Gomez F., Sunyach M.P., D'Hombres A., Carrie C., Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 2004, 22:1447-1453.
44. Poortmans P.M., Collette L., Bartelink H., Struikmans H., Van den Bogaert W.F., Fourquet A., et al. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 " boost versus no boost" trial. Cancer Radiother 2008, 12:565-570.
45. Sanghani M., Raad R.A., Niemierko A., Taghian A., Wazer D. Validation of a Web-based Predictive Nomogram for Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy. Int J Radiat Oncol Biol Phys 2008, 72(S1):S91.
46. Seradour B., Allemand H., Weill A., Ricordeau P. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 2009, 96:E1-E6.
47. Seradour B., Ancelle-Park R. Breast cancer screening: are results of French and international programmes comparable?. J Radiol 2006, 87:1009-1014.
48. Singletary S.E., Allred C., Ashley P., Bassett L.W., Berry D., Bland K.I., et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002, 20:3628-3636.
49. Stone H.B., Coleman C.N., Anscher M.S., McBride W.H. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003, 4:529-536.
50. Thames H.D., Hendry J.H., Moore J.V., Ang K.K., Travis E.L. The high steepness of dose-response curves for late-responding normal tissues. Radiother Oncol 1989, 15:49-53.
51. Trétarre B., Guizard A.V., Fontaine D. Cancer du sein chez la femme: incidence et mortalité, France 2000. BEH 2004, 44:209-210.
52. Truong P.T., Lesperance M.L., Sanghani M., Jones H., Tighouart H., Wazer D., et al. Independent Validation of IBTR! A Computer-based Tool to Predict Ipsilateral Breast Recurrence in Women with Invasive Breast Cancer Treated with Breast Conserving Surgery. Int J Radiat Oncol Biol Phys 2008, 72(S1). # 203.
53. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.
54. Vicini F.A., Kestin L., Huang R., Martinez A. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?. Cancer 2003, 97:910-919.